MOUNTAIN VIEW, Calif. — Complete Genomics Inc. (NASDAQ: GNOM), the complete human genome sequencing company, today announced it has appointed Keith Raffel as chief commercial officer (CCO) and Dr. Jill Hagenkord as chief medical officer (CMO). Both executives will support continued growth in the company’s service offerings and spearhead the development of new products to […]
MOUNTAIN VIEW, Calif. — Complete Genomics Inc. (NASDAQ: GNOM), the complete human genome sequencing company, today announced additional details about the option that SAIC-Frederick Inc. has exercised to have Complete Genomics sequence the DNA from more than 500 pediatric cancer cases. This project was first announced during Complete Genomics’ Q2 earnings call on Aug. 4, […]
Seattle, Wash. – August 23, 2011 – Stratos Genomics Inc. today announced receipt of grant funds from the National Human Genome Research Institute in the amount of $829,000 over two years. The NHGRI, part of the National Institutes of Health (NIH), awarded $14 million to nine qualifying research organizations on Monday, August 22, 2011, to […]
OXFORD, U.K.–Oxford Nanopore Technologies Ltd. is pleased to congratulate Professor Mark Akeson (University of California, Santa Cruz) and his collaborators on the award of a $3.6 million, three year grant by the National Human Genome Research Institute (NHGRI). Professor Akeson has pioneered techniques to control the movement of single stranded DNA (ssDNA) through protein nanopores. […]
Munich, Germany – Genomatix Software, the Uniformed Service University of the Health Sciences (USU), and the Henry M. Jackson Foundation (HJF) for the Advancement of Military Medicine, Inc. have entered into a Cooperative Research and Development Agreement (CRADA) to extend their collaborative endeavors in prostate disease research. The aim of the joint research will be […]
BRANFORD, Conn.–Medicinal Genomics, a private company headquartered in Marblehead, Mass., USA and the Netherlands, announced today that it has sequenced the entire genomes of Cannabis sativa and Cannabis indica, representing two strains of the therapeutic plant. The genome assemblies, comprising over 131 billion bases of sequence, are the largest known gene collection of the Cannabis […]
MARBLEHEAD, Mass. and AMSTERDAM–Medicinal Genomics, a pioneer in the genomics of medicinal plants, today announced that the company has sequenced the entire genome of Cannabis sativa and Cannabis indica, assembling the largest known gene collection of this therapeutic plant. The DNA purification was performed at the company’s research facility in Amsterdam, and the sequencing was […]
HOUSTON–The Department of Homeland Security (DHS) Science and Technology Directorate (S&T) have awarded Eureka Genomics Corporation a $750,000 Phase II SBIR for the detection of rare variants of Bacillus anthracis. After successfully completing a DHS Phase I contract, Eureka Genomics has been awarded a $750,000 Phase II SBIR from The Department of Homeland Security (DHS) […]
SANTA CLARA, Calif., and DURHAM, N.C. – Agilent Technologies Inc. (NYSE: A) and Expression Analysis Inc. today announced that Expression Analysis has achieved Certified Service Provider status for the Agilent SureSelect Target Enrichment System. SureSelect has been shown to greatly increase the speed and cost-efficiency of next-generation sequencing by enabling researchers to focus experiments on […]
Kuala Lumpur, Malaysia – Malaysian Genomics Resource Centre Berhad (MGRC) has announced the extensive update of its comprehensive range of high-speed online bioinformatics analysis tools and reference databases. These free-to-use tools now offer users greater flexibility to perform complex analyses of genomic data with a very short turnaround time. One of the major updates involves […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
